Frontline The Other Drug War
As debate continues over Medicare prescription drug benefits, FRONTLINE investigates the conflict between pharmaceutical companies and U.S. consumers paying the worlds highest drug prices. Interviews with legislators, scientists, consumers, and industry leaders reveal how Maine and Oregon moved to control escalating drug costs despite industry opposition, arguing that price reductions will only reduce the number of new innovative drugs.